These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10784478)

  • 1. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
    Donovan SJ; Stewart JW; Nunes EV; Quitkin FM; Parides M; Daniel W; Susser E; Klein DF
    Am J Psychiatry; 2000 May; 157(5):818-20. PubMed ID: 10784478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
    Donovan SJ; Nunes EV; Stewart JW; Ross D; Quitkin FM; Jensen PS; Klein DF
    J Clin Psychiatry; 2003 Jun; 64(6):698-701. PubMed ID: 12823085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex treatment of disruptive adolescents: a report of 10 cases.
    Donovan SJ; Susser ES; Nunes EV; Stewart JW; Quitkin FM; Klein DF
    J Clin Psychiatry; 1997 Jan; 58(1):12-5. PubMed ID: 9055831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium in substance abusers with mood disorder.
    Albanese MJ; Clodfelter RC; Khantzian EJ
    J Clin Psychiatry; 2000 Dec; 61(12):916-21. PubMed ID: 11206596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
    Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
    Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder.
    Greene RW; Biederman J; Zerwas S; Monuteaux MC; Goring JC; Faraone SV
    Am J Psychiatry; 2002 Jul; 159(7):1214-24. PubMed ID: 12091202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms.
    Chang KD; Dienes K; Blasey C; Adleman N; Ketter T; Steiner H
    J Clin Psychiatry; 2003 Aug; 64(8):936-42. PubMed ID: 12927009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.
    Hollander E; Soorya L; Wasserman S; Esposito K; Chaplin W; Anagnostou E
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):209-13. PubMed ID: 16316486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
    Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome with divalproex in children and adolescents with bipolar disorder.
    Henry CA; Zamvil LS; Lam C; Rosenquist KJ; Ghaemi SN
    J Child Adolesc Psychopharmacol; 2003; 13(4):523-9. PubMed ID: 14977465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.
    West AE; Weinstein SM; Celio CI; Henry D; Pavuluri MN
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):545-53. PubMed ID: 22136096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
    McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
    J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-IV intermittent explosive disorder: a report of 27 cases.
    McElroy SL; Soutullo CA; Beckman DA; Taylor P; Keck PE
    J Clin Psychiatry; 1998 Apr; 59(4):203-10; quiz 211. PubMed ID: 9590677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.